Emergent BioSolutions makes the only FDA-approved anthrax vaccine.


Updates from The Motley Fool

Latest updates on Emergent BioSolutions from Fool.com.


Stock Performance

View Interactive EBS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Emergent BioSolutions.
Current Price: $29.38
Prev Close: $28.84
Open: $28.84
Bid: $28.30
Ask: $30.23
Day's Range: $28.61 - $29.41
52wk Range: $24.47 - $44.38
Volume: 250,174
Avg Vol 322,300
Market Cap: $1B
P/E (ttm): 21.36
EPS (ttm): $1.35
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Emergent BioSolutions.
CAPS Rating 4 out of 5
 
485 Outperform
17 Underperform
CAPS All Stars
 
81 Outperform
4 Underperform

How do you think Emergent BioSolutions will perform against the market?



You pick for Emergent BioSolutions is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Daniel J. Abdun-Nabi, CEO

73% Approve

Based on 69 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Emergent BioSolutions.

Emergent BioSolutions makes the only FDA-approved anthrax vaccine.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers